Photoreceptor Characteristics in Diabetic Retinopathy vs Controls Using Adaptive Optics Imaging: Systematic Review.

IF 0.5 Q4 OPHTHALMOLOGY Journal of VitreoRetinal Diseases Pub Date : 2024-09-30 DOI:10.1177/24741264241286682
Justin Grad, Amin Hatamnejad, Niveditha Pattathil, John Golding, Netan Choudhry
{"title":"Photoreceptor Characteristics in Diabetic Retinopathy vs Controls Using Adaptive Optics Imaging: Systematic Review.","authors":"Justin Grad, Amin Hatamnejad, Niveditha Pattathil, John Golding, Netan Choudhry","doi":"10.1177/24741264241286682","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To assess the differences in morphological photoreceptor outcomes measured using adaptive optics (AO)-assisted imaging between individuals with diabetes or prediabetes and healthy controls. <b>Methods:</b> A systematic search was conducted across MEDLINE, Embase, and Cochrane databases from January 2000 to June 2023. Studies that used AO-assisted imaging modalities to quantitatively compare photoreceptor outcomes in patients with diabetes or prediabetes with healthy controls were included. <b>Results</b>: Eleven studies consisting of 551 eyes were included. Most studies reported significant differences in photoreceptor outcomes between diabetic and healthy populations, particularly as diabetic retinopathy (DR) severity increased. Cone regularity was the most sensitive parameter for detecting significant differences between groups. AO imaging was less reliable in distinguishing individuals with diabetes without DR or with mild DR severity from controls. <b>Conclusions:</b> AO imaging showed promise in detecting significant differences associated with diabetes and DR, in particular with increasing disease severity. Further research is warranted to assess AO's utility as a diabetes and DR screening tool. Standardizing imaging protocols in future studies is recommended to allow for more direct quantitative comparisons. These findings highlight the current evidence on photoreceptor changes in patients with diabetes and the potential of AO in advancing diabetic eye care.</p>","PeriodicalId":17919,"journal":{"name":"Journal of VitreoRetinal Diseases","volume":" ","pages":"24741264241286682"},"PeriodicalIF":0.5000,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556365/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of VitreoRetinal Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/24741264241286682","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To assess the differences in morphological photoreceptor outcomes measured using adaptive optics (AO)-assisted imaging between individuals with diabetes or prediabetes and healthy controls. Methods: A systematic search was conducted across MEDLINE, Embase, and Cochrane databases from January 2000 to June 2023. Studies that used AO-assisted imaging modalities to quantitatively compare photoreceptor outcomes in patients with diabetes or prediabetes with healthy controls were included. Results: Eleven studies consisting of 551 eyes were included. Most studies reported significant differences in photoreceptor outcomes between diabetic and healthy populations, particularly as diabetic retinopathy (DR) severity increased. Cone regularity was the most sensitive parameter for detecting significant differences between groups. AO imaging was less reliable in distinguishing individuals with diabetes without DR or with mild DR severity from controls. Conclusions: AO imaging showed promise in detecting significant differences associated with diabetes and DR, in particular with increasing disease severity. Further research is warranted to assess AO's utility as a diabetes and DR screening tool. Standardizing imaging protocols in future studies is recommended to allow for more direct quantitative comparisons. These findings highlight the current evidence on photoreceptor changes in patients with diabetes and the potential of AO in advancing diabetic eye care.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用自适应光学成像分析糖尿病视网膜病变与对照组的光感受器特征:系统回顾。
目的:评估使用自适应光学(AO)辅助成像技术测量的糖尿病患者或糖尿病前期患者与健康对照组之间感光细胞形态学结果的差异。方法:在美国医学杂志对 2000 年 1 月至 2023 年 6 月期间的 MEDLINE、Embase 和 Cochrane 数据库进行系统检索。纳入了使用 AO 辅助成像模式定量比较糖尿病或糖尿病前期患者与健康对照组光感受器结果的研究。结果:共纳入了 11 项研究,涉及 551 只眼睛。大多数研究报告称,糖尿病患者和健康人群的感光器官结果存在明显差异,尤其是随着糖尿病视网膜病变(DR)严重程度的增加。锥体规则性是检测组间显著差异的最敏感参数。AO 成像在区分无糖尿病视网膜病变或糖尿病视网膜病变严重程度较轻的糖尿病患者与对照组时不太可靠。结论:AO 成像有望检测出与糖尿病和 DR 相关的显著差异,特别是随着疾病严重程度的增加。有必要开展进一步研究,以评估 AO 作为糖尿病和 DR 筛查工具的实用性。建议在今后的研究中规范成像方案,以便进行更直接的定量比较。这些研究结果强调了目前有关糖尿病患者感光器变化的证据,以及 AO 在促进糖尿病眼保健方面的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.20
自引率
16.70%
发文量
0
期刊最新文献
Operative Times in Scleral Buckle Surgery: Influencing Factors and Cost Analysis. From the Editor-in-Chief. Clinical Profiles of Retinal Vasoproliferative Tumors. Serpiginous Choroiditis After COVID-19 Infection. Ischemic Retinopathy Associated With Mantle Cell Lymphoma-Induced Vascular Occlusion.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1